A Message From Our CEO
Damien Hancox, CEO
Scientific Innovation - Hypochlorous Acid (HOCL)
We are a biotech company who specialise in the development and consumer implementation of Hypochlorous Acid (HOCL).
Historically overlooked by Big Pharma, HOCL has almost limitless potential applications. It is one of the most effective biocides known to man. It eradicates all bacteria, mycobacteria, spores, fungi, viruses – including COVID-19 – within 15 seconds. It is 300x stronger than bleach but 100% safe for human use. HOCL is produced by white blood cells in our bodies to fight infections and is one of the main reasons humans have evolved over millions of years.
We are the first biotech company to stabilise, patent and integrate new medical technology to harness the multitude of benefits HOCL has for mass consumer use.
The Partnership - SpectrumX & Spectrum Antimicrobials
Founded in 2016 by Hoji Alimi, Spectrum Antimicrobials Inc are an infection control solutions company. Spectrum Antimicrobials and SpectrumX formed a mutually beneficial partnership in July 2020. SpectrumX holds licenses, for commercialisation of, various applications of the unique HOCL formulations developed by Spectrum Antimicrobials.
HOCl has never previously been patent protectable. This all changed with the creation of Spectrum Antimicrobial’s development of their PKU platform – Spectricept.
It is the only company in the world to have registered a patent on a finished HOCL product. They additionally have created a formulation that not only has excellent shelf life but additionally maintains efficacy in the presence of serum (blood, salvia, dirt etc). This is key because the product works in “real world” conditions where all other HOCL products and manufacturers have failed.
Key Team Members
Click on each team members photo to read more about their role and experience.